• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Research & Development

Clearside bails on AMD, all-in on diabetic macular edema

February 27, 2017 By Sarah Faulkner

Clearside Biomedical

Clearside Biomedical (NSDQ:CLSD) said today it will redirect its R&D efforts from its pre-clinical axitinib wet age-related macular degeneration therapy to its Zuprata diabetic macular edema treatment. The Alpharetta, Ga.-based company said that recent trial results from other companies investigating combination therapies for wet AMD have led Clearside to reconsider its proprietary suspension formulation of […]

Filed Under: Drug-Device Combinations, Featured, Optical/Ophthalmic, Research & Development, Wall Street Beat Tagged With: Clearside Biomedical

Study: Nanotechnology could cut dose of HIV treatment in half

February 27, 2017 By Sarah Faulkner

Study: Nanotechnology could cut dose of HIV treatment in half

Researchers from the University of Liverpool presented data this week evaluating the use of nanotechnology to improve drug therapies for HIV patients. The team touted its data at the Conference on Retroviruses and Opportunistic Infections in Seattle. The trial enrolled healthy patients and evaluated the use of orally-dosed solid drug nanoparticles to optimize HIV therapy, according […]

Filed Under: Featured, Nanoparticles, Research & Development Tagged With: University of Liverpool

Study: Industry funding biases drug trials in favor of sponsors

February 21, 2017 By Sarah Faulkner

Researchers from the University of Sydney published a review this week, concluding that industry-funded drug trials are often biased in favor of the sponsors’ products. According to Lisa Bero of the university’s Charles Perkins Centre, the study provides “definitive evidence that pharmaceutical industry funding of drug studies biases the results and conclusions to look favourable […]

Filed Under: Pharmaceuticals, Research & Development, Wall Street Beat Tagged With: University of Sydney

Researchers develop smart drugs using ‘DNA computers’ for controlled delivery

February 21, 2017 By Sarah Faulkner

Researchers from the Eindhoven University of Technology have developed the 1st “DNA computer” that can detect several antibodies in the blood and perform calculations based on what it detects. The team published their work in Nature Communications and said that it’s an important step towards developing smart drugs that allow for more targeted and controlled medication delivery. […]

Filed Under: Featured, Pharmaceuticals, Research & Development Tagged With: Eindhoven University of Technology

How virtual and mixed reality are changing drug delivery and device design

February 17, 2017 By Sarah Faulkner

How virtual and mixed reality is changing drug delivery and device design

Kai Worrell believes that virtual and mixed reality may change the way companies design medical devices, and he’s putting that idea into practice. “We think it’s going to transform the way we do feasibility testing and cognitive walk-through simulations,” he said. “We think it’s going to help us understand the cognition of our users, clinical […]

Filed Under: Drug-Device Combinations, Featured, Research & Development Tagged With: Boston Scientific, Facebook, Google, johnsonandjohnson, Medtronic, Samsung, Worrell

Insulet touts Omnipod Horizon hybrid closed-loop system in patients with T1D

February 17, 2017 By Sarah Faulkner

Insulet

Insulet (NSDQ:PODD) touted data today from the 1st feasibility study of its Omnipod Horizon hybrid closed-loop system in patients with Type 1 diabetes.  Data from the study showed that the Omnipod automated glucose control algorithm performed well, with minimal hypoglycemia, and that it was safe. The Billerica, Mass.-based company enrolled 24 patients with Type 1 diabetes […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Research & Development, Wall Street Beat Tagged With: Insulet

Virus shells target and deliver drugs to cancer cells

February 15, 2017 By Sarah Faulkner

Virus shells target and deliver drugs to cancer cells

Researchers from Australia and the UK have developed virus-like nanoparticles to target and deliver drugs to cancer cells. The team’s work, which was published in the journal ACS Nano, showed that the particle could be produced in plants and that it can shuttle small molecules to cancer cells for targeted treatment. The team, lead by Frank […]

Filed Under: Featured, Nanoparticles, Research & Development

ICU Medical touts dosing errors study

February 15, 2017 By Sarah Faulkner

ICU Medical

ICU Medical (NSDQ:ICUI) said today that a multi-hospital study showed improvements in potentially catastrophic dosing errors and drug library compliance when its Plum infusion pumps and Hospira (NYSE:HSP) MedNet safety software were integrated with the hospitals’ electronic medical records. The rate of potentially catastrophic dosing errors fell by 52% after smart-pump EMR integration, the study found, […]

Filed Under: Featured, Hospital Care, Pharmaceuticals, Research & Development, Wall Street Beat Tagged With: Hospira Inc., ICU Medical, Pfizer Inc.

Abbott touts association between monitoring and improved glucose control

February 15, 2017 By Sarah Faulkner

Abbott

Abbott (NYSE:ABT) touted results today from real-world use data for its FreeStyle Libre blood glucose monitoring system. The data showed that people using its FreeStyle Libre system to monitor their glucose levels spend less time in hypoglycemia or hyperglycemia and have improved average glucose levels. More than 50,000 diabetes patients using the FreeStyle Libre system checked […]

Filed Under: Clinical Trials, Diabetes, Featured, Patient Monitoring, Research & Development Tagged With: Abbott Laboratories

Tiny magnetic implant delivers drug locally

February 14, 2017 By Sarah Faulkner

Tiny magnetic implant delivers drug locally

Researchers from the University of British Columbia have developed a magnetic drug implant that measures just 6 millimeters in diameter and can deliver a drug locally to a targeted tissue. The team’s work was published in the journal Advanced Functional Materials. The device is a silicone sponge with magnetic carbonyl iron particles, wrapped in a round […]

Filed Under: Drug-Device Combinations, Featured, Implants, Research & Development Tagged With: University of British Columbia

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 34
  • Page 35
  • Page 36
  • Page 37
  • Page 38
  • Interim pages omitted …
  • Page 48
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS